Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2025-09-17 00:00:00 ET · period of report 2025-09-15 · accession 0001477384-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-09-17 | 2025-09-15 | ANAB | Orwin John A | Dir | M - OptEx | $0.00 | +1,300 | 10.7K | +14% | $0 |
| D | 2025-09-17 | 2025-09-15 | ANAB | Orwin John A | Dir | M - OptEx | $0.00 | -1,300 | 1,300 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-15 | M | A | 1,300 | $0.00 | 10,665 | D | — | — | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. |
| 2 | Derivative | Restricted Stock Unit | 2025-09-15 | M | D | 1,300 | $0.00 | 1,300 | D | — · — to — | 1,300 Common Stock | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F2) The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date. |